Bio-Gene Technology’s novel acaricide Flavocide demonstrated over 90% mortality against Lyme disease-carrying ticks in lab tests presented by Purdue University, highlighting its potential in public health applications.
Elders Limited has reported a robust 67% increase in underlying EBIT for the half-year ending March 2025, driven by livestock market recovery and real estate growth, alongside five new acquisitions and ongoing transformation initiatives.
Elders Limited has reported a robust 67% increase in underlying EBIT for the first half of FY25, driven by higher livestock prices and strategic acquisitions, while navigating challenges from dry weather impacting crop inputs.